Results 71 to 80 of about 4,088,174 (172)

Expert consensus on clinical trial design guidelines for FLASH radiotherapy

open access: yesPrecision Radiation Oncology, EarlyView.
• FLASH radiotherapy has emerged as a transformative technology due to the underlying FLASH effect. • As FLASH radiotherapy moves toward clinical application, establishing standardized trial design principles is critical. • This expert consensus provides a roadmap for rigorous clinical evaluation of FLASH radiotherapy, accelerating safe translation of ...
Hui Luo   +9 more
wiley   +1 more source

Salvage Reirradiaton With Stereotactic Body Radiotherapy for Locally Recurrent Head-and-Neck Tumors

open access: yes, 2011
Purpose: In this study. we present our results of reirradiation of locally recurrent head-and-neck cancer with image-guided, fractionated, frameless stereotactic body radiotherapy ...
Gözde Yazici   +19 more
core   +1 more source

The role of technology in clinical trials using stereotactic body radiotherapy [PDF]

open access: yes, 2017
Stereotactic body radiotherapy is a highly technology-driven treatment modality. The wider availability of in-room imaging and advanced radiotherapy delivery techniques has led to more institutions offering stereotactic ablative therapy (SABR).
Aznar, M.C. (Marianne C.)   +13 more
core   +1 more source

Implementation and preliminary evaluation of a practical digital workflow for routine laser‐radiation field coincidence quality assurance on the CyberKnife M6

open access: yesPrecision Radiation Oncology, EarlyView.
An MLC QA tool–QASC–CKQA workflow achieved the lowest laser‐radiation field coincidence deviations on CyberKnife M6, supporting a simpler, more reproducible routine QA strategy. When QASC is unavailable, the film‐based MLC QA tool workflow provides a practical alternative.
Linzheng Hu   +8 more
wiley   +1 more source

Comparison of intracavitary brachytherapy and stereotactic body radiotherapy dose distribution for cervical cancer

open access: yes, 2012
PURPOSE: To compare the dose distribution characteristics of stereotactic body radiotherapy (SBRT) with intracavitary high-dose-rate (HDR) brachytherapy in patients with cervical ...
CENGİZ, MUSTAFA   +8 more
core   +1 more source

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview

open access: yesFrontiers in Oncology, 2019
The oligometastatic state is hypothesized to represent an intermediary state of cancer between widely metastatic disease and curable, localized disease.
Kang Liang Zeng   +5 more
doaj   +1 more source

Feasibility of Urethra‐Sparing Ultra‐Hypofractionated Three‐Dose‐Level Radiotherapy for Prostate Cancer with a Dominant Intraprostatic Lesion Abutting the High‐Dose Avoidance Zone

open access: yesPrecision Radiation Oncology, EarlyView.
Ultra‐hypofractionated three‐dose‐level radiotherapy allows safe dose escalation to dominant intraprostatic lesions near the urethra while maintaining full coverage of pelvis and prostate and respecting urethral and organ‐at‐risk constraints. Abstract This planning study evaluated ultra‐hypofractionated three‐dose‐level radiotherapy for prostate cancer
Annalisa Muscato   +4 more
wiley   +1 more source

Stereotactic Radiotherapy in Uveal Melanoma

open access: yes, 2014
Uveal melanoma is the most common primary malignant intraocular neoplasm in adults. The aims of treatment of the uveal melanoma are to prevent the metastatic spread of the disease and to preserve as much useful vision as possible.
Ela Delikgöz Soykut   +2 more
core   +1 more source

Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung - The Knockout Punch

open access: yes, 2022
This overview summarises the current evidence on efficacy and safety of single-fraction stereotactic ablative body radiotherapy (SABR) for primary lung cancers and lung metastases, in comparison with the more widely adapted multi-fraction SABR regimens ...
Guckenberger, M.   +21 more
core   +1 more source

The changing role of radiation therapy in the management of oligometastatic disease

open access: yesTechnical Innovations & Patient Support in Radiation Oncology, 2017
It is clear from surgical series that there are selected patients presenting with localised metastatic disease who can be cured by radical ablation of the metastasis.
H. Tharmalingham, P.J. Hoskin
doaj   +1 more source

Home - About - Disclaimer - Privacy